Clinical Trial Update: 18F-DCFPyL Positron Emission Tomography (PET)/Computed Tomography (CT) in Men With Prostate Cancer [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for 18F-DCFPyL PET/CT in men with prostate cancer, spanning Phase 2 and Phase 3, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostatic Neoplasms

Drugs mentioned

• 18F-DCFPyL (DCFPyL radiotracer for PSMA imaging)

Snippet

Sponsor: Columbia University | Conditions: Prostatic Neoplasms | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING